Suez Canal University

scu.edu.eg

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

151

Active

42

Phase 3

6

Total enrollment

309,344

Pipeline matrix

Showing 17 of 17 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Intranasal dexmedetomidine1
Intranasal normal saline1
non surgical with PUFA1
Calcium Hydroxide Intracanal medication1
Calcium silicate based intracanal medication1
Pectin1
Normal Saline5
Melatonin gel1
Mineral trioxide aggregate1
Melatonin1
Hyaluronic Acid gel1
Active oxygen gel1
Norepinephrine1
Ondansetron 8mg1
ondansetron lingual film1
vit D mixed with xenograft1
only xenograft without vit D1

Next readouts

  • 2024-09-20
  • 2025-06-15
  • 2025-08-07
  • 2026-03-10
  • 2026-04
  • 2026-07-01
  • 2026-07-20
  • 2026-08-27
  • 2026-10
  • 2026-10-10

Top conditions

  • Postoperative Pain6
  • Implant Therapy3
  • Dental Caries in Children3
  • Carcinoid Tumor3
  • Tooth Loss3
  • Periodontitis2
  • Postoperative Analgesia2
  • Dental Implants2

Frequently asked questions about Suez Canal University

How many clinical trials does Suez Canal University have on ClinicalTrials.gov?
Suez Canal University is listed as the lead sponsor on 151 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
How many of Suez Canal University's trials are in Phase 3?
6 of Suez Canal University's trials are in Phase 3, spread across 17 active drug programs.
What therapeutic areas does Suez Canal University focus on?
Suez Canal University's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Implant Therapy, Dental Caries in Children, Carcinoid Tumor, Tooth Loss.
When are Suez Canal University's next clinical trial readouts?
Suez Canal University has 10 upcoming primary-completion readouts tracked here; the soonest is “Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study”, expected around 2024-09-20.